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Abstract
 .Nitric oxide NO synthase activity, which converts arginine to citrulline and NO, is present in homogenates of rat gastric
mucosal cells. The aims of this study were to identify the form of NO synthase expressed in gastric cells isolated from fed
rats, and to investigate the metabolism of arginine by suspensions of intact mucosal cells. Antibodies directed against the
neuronal form of NO synthase recognised a protein of 160 kDa on immunoblots of extracts of gastric cells, and stained
isolated cells of approx. 8 mm in diameter. NO synthase was enriched in a cell fraction which banded at high-density in a
 . G  . G  .Percoll gradient, and was inhibited IC by N -nitro-L-arginine 0.8 mM , N -monomethyl-L-arginine 12.6 mM ,50
 .  .L-canavanine 147 mM , trifluoperazine 140 mM and by phosphorylation involving protein kinase C. Intact gastric cells
converted exogenous arginine to ornithine and citrulline. Arginase was present in the cells, and was predominantly
responsible for arginine metabolism because formation of ornithine and citrulline was reduced by the arginase inhibitors,
N G-hydroxy-L-arginine and L-ornithine, but not by NO synthase inhibitors such as N G-nitro-L-arginine. In conclusion, NO
synthase that resembles the neuronal isoform is present in gastric mucosal cells, but a pathway involving arginase seems to
be largely responsible for citrulline formation from exogenous arginine in intact mucosal cells.
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1. Introduction
 .In the gastric mucosa nitric oxide NO is an
important component of mechanisms responsible for
maintaining mucosal integrity and for regulating blood
Abbreviations: NO, nitric oxide; Neuronal, endothelial and
inducible forms of nitric oxide synthase, nNOS, eNOS and iNOS
respectively
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w xflow to the epithelium 1 . NO is produced from
arginine by NO synthase, which was associated with
a fraction of isolated gastric mucosal cells enriched
w xwith mucous cells 2 . The mucus layer in the stom-
ach forms an important component of the barrier
which protects the mucosa from damage by acid and
w xpepsin 3 , and NO donors and analogues of cyclic
GMP-stimulated mucus secretion by suspensions of
w xgastric cells 4 .
NO synthases can be categorised into three major
w x 2q  .forms 5 . A Ca -independent form iNOS can be
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induced in gastric mucosal cells by injecting lipo-
w xpolysaccharide into rats in vivo 6 , but iNOS is
likely to be absent from mucosal cells obtained from
normal fed rats because all of the NO synthase
2q w xactivity in these cells is Ca -dependent 2,6 . The
other two major forms of NO synthase are both
dependent on Ca2q for activity and are the neuronal
 .  . w xform nNOS and the endothelial form eNOS 5 .
Neither of these forms is restricted to the tissue after
which they are named, for example eNOS is also
w xfound in renal epithelial cells 7 . In this present
study, immunological methods have been used to
determine the form of Ca2q-dependent NO synthase
which is present in isolated gastric mucosal cells, and
the effects of arginine analogues, the calmodulin
antagonist trifluoperazine, and enzyme phosphoryla-
tion on activity of NO synthase have been examined.
Arginine may also be metabolised by arginase to
ornithine and urea. Arginase and NO synthase have
been found together in rat coronary endothelial cells
w x w x8 , in small intestinal mucosal cells 9 , and are
co-induced by lipopolysaccharide in macrophages
w x10 . Furthermore, interactions between the NO syn-
thase and the arginase metabolic pathways have been
w xsuggested 11,12 . In the current work, the presence
of arginase in gastric mucosal cells has been investi-
gated, and the effect of inhibitors of arginase and NO
synthase on formation of labelled metabolites from
w3 xL- H arginine has been used to elucidate pathways
responsible for metabolism of arginine in intact cells.
2. Materials and methods
2.1. Materials
Mouse monoclonal antibodies to a 22.3 kDa frag-
ment corresponding to amino acids 1095–1289 of
human brain NO synthase, to a 20.4 kDa fragment
corresponding to amino acids 1030–1209 of human
endothelial NO synthase and to a 21 kDa fragment
 .amino acids 961–1144 from mouse macrophage
NO synthase were obtained from Transduction Labo-
ratories, Lexington, KY, USA. The C-terminal hex-
adecapeptide of rat brain NO synthase residues
.1414–1429 , synthesised with a cysteine residue
added to the amino-terminus of the sequence, was
coupled to keyhole-limpet haemocyanin via reaction
with the cysteine sulfydryl by Affiniti, Exeter, UK
and was used to raise an antipeptide antibody in
rabbits. The bicinchoninic acid protein determination
kit was purchased from Pierce, Rockford, IL, USA.
The Vectastain Elite ABC kit was obtained from
Vector Laboratories, Peterborough, UK. Mouse mon-
oclonal antibody to rat RECA-1 antigen, and strepta-
vidin-conjugated fluorescein isothiocyanate were
bought from Serotec, Oxford, UK. Adenylyl- b ,g-
.methylene -diphosphonate was obtained from
Boehringer, Lewes, UK. N G-monomethyl-L-arginine
was synthesised at the Wellcome Research Laborato-
ries, Beckenham, UK. Chelerythrine and N G-hy-
droxy-L-arginine were obtained from Alexis, Notting-
w 14 x w 3 xham, UK. U- C L-arginine, L- 2,3,4,5- H arginine,
w 3 x w 14 x w14 xL- 2,3,4,5- H citrulline, L- 1- C ornithine, C -
PEG 4000, and the enhanced chemiluminescence im-
munoblotting kit were from Amersham International,
w 14 xLittle Chalfont, UK. L- guanido- C arginine was
from Du Pont NEN, Stevenage, UK. Pronase was
from Merck, Lutterworth, UK and the other reagents
were from Sigma, Poole, UK.
2.2. Preparation and fractionation of isolated cells
Isolated cells were prepared by subjecting everted
sacs of rat corpus to digestion with pronase and to
2q w xintermittent chelation of Ca with EDTA 13 . Frac-
tionation of cells on a self-forming Percoll gradient
involved resuspension of the unenriched cells in Ea-
gle’s minimum essential medium containing: isotonic
Percoll, 36 mlr100 ml; Hepes, 12 mM; bovine serum
albumin, 0.6 mgrml; dithiothreitol, 0.3 mM and
EGTA, 1.8 mM, followed by centrifugation for 13
min at 30,000 g at 48C using a 208 angle rotor in anav
MSE Superspeed 50 centrifuge. Two main zones of
cells are produced. In the low-density fraction, cen-
tred on 1.029 grml, 84"2% of the cells were
parietal cells while in the high density fraction, cen-
tred on 1.059 grml, 11"2% of the cells were
 .parietal cells ns7 . Viability was assessed by ex-
posing cells to 0.5% trypan blue in phosphate-buffered
saline. The number of viable cells which excluded the
dye was always greater than 90%.
2.3. Immunoblotting
 .Tissues were homogenised Ultra-Turrax with
boiling electrophoresis sample buffer 0.0625 M Tris,
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pH 6.8, 10% vrv glycerol, 2% wrv sodium dodecyl-
.sulfate , which was also added to pellets of isolated
cells, and the extracts were then boiled for 5 min.
The protein concentration in extracts was determined
by the bicinchoninic acid procedure, the samples
were made 0.1 M with dithiothreitol and reboiled.
Samples were separated by sodium dodecylsulfate
 .polyacrylamide gel electrophoresis 8% acrylamide
and were transferred to nitrocellulose. Blots were
blocked for 1 h at room temperature with non-fat
 . dried milk 5% wrv , dissolved in 10 mM Tris pH
.  . 7.5 100 mM NaCl and 0.1% vrv Tween 20 TBS-
.Tween , and were then exposed to polyclonal anti-
serum to the C-terminal hexadecapeptide of rat brain
NO synthase at a dilution of 1r1250 or to mono-
clonal antibodies directed against neuronal, endothe-
lial or inducible NO synthase at concentrations of 1
mgrml. All antibodies were diluted into blocking
medium. After washing in TBS-Tween, binding of
primary antibodies was detected with an appropriate
anti-species IgG antibody conjugated with horseradish
peroxidase followed by enhanced chemiluminescence
detection.
2.4. Immunocytochemistry
Isolated cells were transferred to microscope slides
by using a cytocentrifuge, were allowed to dry in air
and were fixed by exposure to acetone at 48C for 5
min. Staining for NO synthase involved treating slides
 .with 0.75% vrv hydrogen peroxide for 30 min to
inhibit endogenous peroxidase, washing in phos-
 .phate-buffered saline PBS , and blocking non-
specific binding by exposure for 20 min to 5% goat
serum in PBS. The cytospin preparations were then
 .exposed to monoclonal antibodies 10 mgrml to NO
synthases for 30 min at room temperature. Mouse
monoclonal antibody of irrelevant specificity was
used as the control. After washing with PBS, cy-
tospin preparations were incubated with biotinylated
anti-mouse IgG and binding of the secondary anti-
body was detected by using avidin-biotinylated-
peroxidase reagent with diaminobenzidine as the per-
oxidase substrate.
Experiments for the detection of endothelial cells
involved incubation of cytospin preparations with
successively: 5% normal goat serum in PBS, avidin
D and biotin blocking solutions, PBS, a mouse mono-
w x clonal antibody to rat RECA-1 antigen 14 undi-
.luted culture supernatant or monoclonal antibody to
 .endothelial NO synthase 10 mgrml . Slides were
then washed, exposed to biotinylated anti-mouse IgG
antiserum, washed again and finally incubated with
streptavidin-conjugated fluorescein isothiocyanate 20
.mgrml and viewed on a Jenamed 2 fluorescence
microscope. These immunofluorescence procedures
were validated by using 10 mm cryostat sections of
gastric mucosa where endothelial staining with both
antibodies was clearly visible.
2.5. Assay of NO synthase, arginase and ornithine
transcarbamoylase
Enzyme activity was released from isolated cell
 .fractions into homogenisation buffer pH 7.4 consist-
ing of: Hepes, 10 mM; sucrose, 0.32 M; EDTA, 0.1
mM; dithiothreitol, 1 mM; soybean trypsin inhibitor,
10 mgrml; leupeptin, 10 mgrml; aprotinin, 6 mgrml
and phenylmethylsulfonyl fluoride, 0.1 mgrml, by
freezing on dry ice and thawing at 378C three times.
The homogenisation buffer for assay of arginase dif-
fered from that for NO synthase by the addition of 1
mM MnCl . Whole homogenates were used for assay2
of ornithine transcarbamoylase activity. Supernatants,
prepared by centrifugation of homogenates, at 10 000
=g for 20 min at 48C were used for assay of NO
synthase or arginase activity. In experiments measur-
ing the potency of inhibitors of NO synthase, high-
density cell fractions enriched in NO synthase were
used and supernatants were passed through a column
 .of Sephadex G-25 0.7=8 cm to remove endoge-
nous arginine.
NO synthase activity was assayed by following the
w 14 x w14 xconversion of L- U- C arginine to C citrulline as
w x  .described previously 2 , with valine 7 mM present
in the assay system, and was defined as citrulline
formation inhibitable by 100 mM N G-monomethyl-
L-arginine.
Arginase activity was determined by measuring the
w 14 x w14 xconversion of L- guanido- C arginine to C urea
w x  .12 . Homogenate 50 ml was added to 150 ml of
 .assay buffer 100 mM glycine pH 9.7 and the reac-
tion started by the addition of 50 ml of 250 mM
warginine containing 111,000 dpm of L- guanido-
14 xC arginine. Incubation was for 15 min at 378C after
which the reaction was terminated by the addition of
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0.8 ml of stop buffer 250 mM acetic acid, 100 mM
.urea and 10 mM L-arginine, pH 4.5 , and 400 ml of a
 q .50% suspension of Dowex 50-WX8 resin H form .
The resin was allowed to settle and urea in the
supernatant was measured by scintillation counting.
Under these conditions, the resin removed 99.7% of
wthe arginine substrate and 95% of added L- 2,3,4,5-
3 xH citrulline.
Ornithine transcarbamoylase activity was assayed
w x8 as the stimulation of citrulline formation from
w 14 x  .L- 1- C ornithine 0.22 mCirml by 10 mM car-
bamoyl phosphate in an assay medium consisting of
 .100 mM potassium phosphate buffer pH 7.5 and 20
mM L-ornithine. Citrulline was separated from or-
 .nithine by thin-layer chromatography see below 2.7. .
2.6. Metabolism of arginine and citrulline by isolated
cells
The incubation medium was Krebs bicarbonate
 .buffer pH 7.4 containing: 118 mM NaCl, 4.7 mM
KCl, 1.2 mM MgSO , 1.2 mM KH PO , 25 mM4 2 4
NaHCO , 1.25 mM CaCl , 11 mM glucose, and3 2
 60.1gr100 ml bovine serum albumin. Cells 5=10
.cellsrml were preincubated for 15 min at 378C in
medium alone, or with the addition of the arginase
w x G  .inhibitors 15 N -hydroxy-L-arginine 4 mM and
 .L-ornithine 1 mM , or the NO synthase inhibitor,
G  . w xN -nitro-L-arginine 0.3 mM 5 . Aliquots of cells
w 3 xwere then exposed to L- 2,3,4,5- H arginine or L-
w 3 x 2,3,4,5- H citrulline respectively 3 mCirml, 43 nM
.and 1.3 mCirml, 20 nM in 20 ml polyethylene vials
for between 5 and 15 min. An extracellular volume
w14 x  .marker, C -PEG 4000 0.4 mCirml , was included
in some experiments. The suspensions were cen-
trifuged at 10 000=g for 2 s and cell pellets were
extracted overnight at 48C with 200 ml of 65%
ethanol containing 0.5 mgrml of each of the unla-
belled amino acids arginine, ornithine and citrulline.
Extracts were analysed by ion-exchange chromatog-
raphy on Dowex 50-WX8, or by thin-layer chro-
matography on silica gel 60 plates with
chloroform:methanol:ammonium hydroxide 2:2:1 by
.volume as the solvent. Radioactivity associated with
arginine, ornithine and citrulline was determined by
liquid scintillation counting. The formation of
metabolites was expressed as a percentage of the total
3H associated with the pellet, or as a percentage of
intracellular radioactivity.
2.7. Expression of results and statistical analysis
Results are presented as means"S.E.M. with n
representing the number of batches of isolated cells,
each batch being prepared on a separate occasion, or
for other experiments the number of animals. Com-
parison of two sets of data was performed by using
Student’s t test. Several treatments were compared by
analysis of variance, which served to remove the
effect of variation due to cell batches, followed by
Dunnett’s test.
3. Results
3.1. Immunodetection of NO synthases
Immunoblots of extracts of brain, gastric mucosa
and isolated mucosal cells exhibited a band at 160
kDa when exposed to either the antipeptide antibody
directed against the carboxyl-terminus of rat brain
NO synthase or the monoclonal antibody to human
 .neuronal NO synthase Fig. 1a This band was more
intense in the extracts made from cells of high-den-
 .sity than from extracts of low-density cells Fig. 1b .
Exposure of nitrocellulose blots to an antibody di-
rected against endothelial NO synthase produced a
band at 140 kDa only with intact mucosa but not with
 .isolated cell preparations Fig. 1b .
Cells of diameter close to 8 mm were stained by
the monoclonal antibody to human neuronal NO syn-
 .thase using an immunoperoxidase procedure Fig. 2 .
The much larger parietal cells were unstained. The
mean diameter of periodic-acid Schiff-positive mu-
cous cells in elutriator fraction 3, in which NO
w x synthase was enriched 2 , was 7.7"0.22 mm ns4,
.J. Brown, unpublished work . No staining was ob-
served if non-specific IgG, or antibody directed
against endothelial NO synthase, were used. Use of
immunofluorescence procedures with isolated cells
gave negative results for both antibody to endothelial
NO synthase or the pan-endothelial cell-specific
w xmonoclonal antibody RECA-1 14 .
An antibody directed against iNOS recognised a
band at 130 kDa on immunoblots of macrophages
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Fig. 1. a. Immunoblotting of NO synthase extracted from unen-
riched preparations of isolated gastric mucosal cells. Lanes 1–4
blot exposed to C terminal antipeptide antibody to rat brain NO
synthase. Lanes 5–8, blot exposed to a monoclonal antibody
directed against a region of human neuronal NO synthase. Load-
 .ing of lanes with mg protein in parenthesis: 1, 5 brain 50 ; 2, 6
 .gastric mucosa 100 ; 3, 7 and 4, 8 two different preparations of
 .isolated cells 100 . Similar results were obtained on two other
occasions. b. Immunoblotting of NO synthase extracted from
different fractions of gastric mucosal cells. Lanes 1–4 blot ex-
posed to monoclonal antibody directed against a region of human
neuronal NO synthase. Lanes 5–8 blot exposed to monoclonal
antibody directed against a region of human endothelial NO
 .synthase. Loading of lanes 100 mg protein : 1 and 5, gastric
mucosa; 2 and 6, unenriched gastric mucosal cells; 3 and 7 a
high-density Percoll fraction; 4 and 8 a low-density Percoll
fraction. Similar results were obtained on two other occasions.
 .activated with lipolysaccharide 1 mgrml and inter-
 .feron g 10 ngrml , and of colonic tissue taken from
rats pre-treated with lipolysaccharide in vivo 3
.mgrkg i.v. 4h previously . However, no such reac-
Fig. 2. Immunocytochemistry of cells isolated from rat corpus
glandular mucosa exposed to monoclonal antibody to neuronal
NO synthase. Bars50 mm.
tion was seen with extracts of gastric mucosal cells
 .ns3 .
3.2. Inhibition of NO synthase in mucosal cells
 .NO synthase activity was inhibited, IC mM in50
G  . Gparenthesis, by N -nitro-L-arginine 0.8 , N -mono-
 .  .methyl-L-arginine 12.6 , L-canavanine 147 and tri-
 .  .fluoperazine 140 Fig. 3a,b . Addition of 10 mM
MgCl and 5 mM ATP to the homogenisation buffer2
used for freeze-thawing the isolated cells effected a
38"5% inhibition of NO synthase activity relative
 .to controls without such addition P-0.01, ns6 .
Retention of Mg2q, but substitution of ATP with
either the non-hydrolysable analogue adenylyl- b ,g-
Fig. 3. Properties of NO synthase extracted from a high-density
fraction of isolated cells. A. Inhibition by N G-nitro-L-arginine
 . G  .triangles , N -monomethyl-L-arginine squares and L-
 .canavanine circles . Results are means"S.E.M. of three separate
batches of cells and are expressed as percentage inhibition of
control activity which was 1.4"0.29 pmolrmin per million cells.
B. Inhibition by trifluoperazine. Data are mean"SEM of five
separate batches of cells with uninhibited activity being 1.8"0.67
pmolrmin per million cells.
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Table 1
Arginase and NO synthase activity in cell fractions isolated from
the rat gastric mucosa
Cell fraction Arginase pmolrmin NO synthase pmolrmin
per million cells per million cells
Unenriched 2 080"280 0.25 "0.087
)) ))High-density 786"275 0.70 "0.091
Low-density 2 070"551 0.044"0.032
Results are means"S.E.M. of five separate preparations of cells
for measurement of arginase and of 10 preparations for NO
synthase.
)) P -0.01 for comparison of activity in the high density
fraction with that in the unenriched fraction by analysis of
variance and Dunnett’s test.
.  . methylene -diphosphonate 5 mM , or with GTP 5
.mM gave NO synthase activities which were in-
significantly changed, 6.2"8.7% and y2.4"11%
 .respectively relative to control activity ns4 . The
effect of ATP and Mg2q in the homogenisation
 .buffer was reduced P-0.05 from 38.3"4.7%
inhibition of NO synthase activity to 21.9"5.4%
inhibition by the presence of 7 mM chelerythrine
 .ns6 . However, the cyclic AMP-dependent protein
 .kinase inhibitory peptide Sigma P6062, 2mM did
not affect the inhibition by ATPrMg2q which was
43"4.2% in the absence, and 35"6.6% in the
 .presence of peptide ns6 .
3.3. NO synthase, arginase and ornithine transcar-
bamoylase in isolated mucosal cells
 .NO synthase and arginase Table 1 , together with
ornithine transcarbamoylase 93"32 pmolrmin per
.million cells, ns5 , were detected in unenriched
suspensions of gastric mucosal cells. Arginase activ-
ity in the high-density fraction was lower than the
activity in an unenriched fraction of isolated cells
 .Table 1 . By contrast NO synthase was greater in the
high-density fraction than in the unenriched fraction
 . w x GTable 1 , 2 . Inclusion of N -monomethyl-L-
 .arginine 100 mM in the arginase assay, which
causes nearly complete inhibition of NO synthase in
w xhomogenates of gastric mucosal cells 2 , gave an
 .arginase activity which was 89"14% ns4 , of
that in the absence of inhibitor no difference by
.t-test .
3.4. Metabolism of arginine by isolated mucosal cells
w3 xIncubation of isolated cells with H arginine for
15 min followed by extraction of the pellet and
analysis of the distribution of label by thin-layer
chromatography gave the following results % of
.label added to the thin-layer plate, ns4 : arginine,
67"4.4; ornithine, 8.5"1.1; citrulline, 15"2.1.
Fig. 4. Metabolism of arginine by unenriched preparations of
isolated gastric mucosal cells. A. Effect of preincubation for 15
 . min in medium alone clear bars , with 1 mM L-ornithine hatched
. G  .bars and with 4 mM N -hydroxy-L-arginine stippled bars on
the proportion of the intracellular label in ornithine and citrulline
w3 x5 min after the addition of H arginine. B. Effect of preincuba-
tion for 15 min with 300 mM N G-nitro-L-arginine on the
w3 xmetabolism of H arginine in the presence and absence of 2 mM
A23187. Results, in both A and B, are means"SEM of triplicate
determinations using four separate batches of cells. ) P -0.05,
)) P -0.01 for difference from control by analysis of variance
and Dunnett’s test.
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Comparable values obtained if label was incubated
 .without cells all different P-0.05 by t-test were:
arginine, 89"5.9; ornithine, 0.18"0.013; and cit-
rulline, 0.12"0.04. If citrulline was analysed by
ion-exchange chromatography then the results % of
.label eluted from the Dowex column, ns4 were:
13"1% in the presence of cells; and 0.33"0.1% in
 .their absence P-0.01 . There was a small, but
 .significant P-0.05 by t test, ns4 , conversion of
w3 xH citrulline to arginine after 15 min of incubation:
0.85"0.29% of label as arginine in the presence of
cells, 0.31"0.07% with the cells absent analysis by
.thin-layer chromatography .
w xPreincubation with arginase inhibitors 15 reduced
 . 3P-0.01, ns4 the total intracellular H in the
w3 xpellet after 5 min incubation with H arginine from a
 6 .control value dpmr10 cells of 10981"1204 to
 .4658"452 and 2643"352 with L-ornithine 1 mM
G  .and N -hydroxy-L-arginine 4 mM , respectively.
Metabolism of arginine was also affected since the
proportion of intracellular 3H in ornithine and cit-
rulline was significantly reduced after preincubation
with L-ornithine and with N G-hydroxy-L-arginine
 .Fig. 4A . Labelled ornithine and citrulline were not
detectable in the incubation medium.
w3 xTotal intracellular H after 5 min incubation with
w3 xH arginine was 10 789"1523 dpmrmillion cells
G after preincubation with N -nitro-L-arginine 300
. 2qmM , or 8634"1332 dpmrmillion cells if the Ca
 .ionophore, A23187 2 mM , was added with argi-
nine. Neither result differed significantly from the
 .control value of 10897"560 ns4 . The proportion
of the label as ornithine was slightly, but significantly
increased by preincubation with N G-nitro-L-arginine
or by the presence of A23187 but there was no effect
 .on the proportion of the label as citrulline Fig. 4B .
A similar lack of effect on citrulline formation com-
pared to the control was obtained in experiments
where 2 mM ionomycin was used instead of A23187,
or if other inhibitors of NO synthase such as N G-
 .nitro-L-arginine methyl ester 300 mM or 7-
 .nitroindazole 1 mM were used.
4. Discussion
A major finding of this investigation is that the
form of NO synthase present in gastric cells isolated
from the glandular corpus mucosa belongs to the
nNOS type. Immunoblots of extracts of isolated cells
when exposed to two different antibodies directed
against nNOS gave bands, at the expected position of
w x160 kDa 5 , at the same position as the band given
by an extract of rat brain. The 160 kDa material was
enriched in the high-density Percoll fraction but de-
pleted from the low-density fraction, which parallels
the distribution of NO synthase activity in suspen-
 . w xsions of isolated cells Table 1 , 2 . Furthermore,
centrifugal elutriation experiments performed previ-
w xously 2 demonstrated that the cell fraction with the
highest NO synthase activity contained periodic
acid-Schiff positive cells, which on slides prepared
by the cytospin procedure, had an average diameter
of 8 mm. The present work showed that cells of a
similar diameter stained with antibody to nNOS but
not to eNOS. These data are therefore evidence that
the NO synthase activity in the elutriator fraction 3
derived from nNOS.
Extracts of gastric mucosa gave a band at the
appropriate position for eNOS when blots were ex-
posed to an antibody directed against this form. No
such bands were seen with extracts of isolated cells.
An explanation, which is supported by the results
obtained with the pan-endothelial specific mono-
clonal antibody, is that endothelial cells are the source
of this eNOS, and are present in the gastric mucosa
but are absent from the isolated cell preparations. The
monoclonal antibody to nNOS gave some bands in
the region of 140 kDa on immunoblots of isolated
cells, but similar bands were absent from samples of
gastric mucosa. These bands are therefore unlikely to
represent a cross-reactivity of the nNOS antibody
with eNOS since they should then have appeared
with mucosal samples as well.
Ca2q-independent NO synthase activity was not
w xpresent in gastric mucosal cells from normal rats 2 .
The implied absence of the inducible form of NO
synthase was supported by a lack of immunoreactiv-
ity corresponding to iNOS on immunoblots of ex-
tracts of isolated cells. Furthermore, the Ca2q-depen-
dent NO synthase activity in the high-density cells
was pharmacologically-distinguishable from Ca2q-in-
dependent NO synthase by N G-nitro-L-arginine being
a more potent inhibitor than N G-monomethyl-L-
w xarginine 16 , and by the low inhibitory potency of
w xL-canvanine 5 . The inhibitory effect of trifluopera-
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zine implies that calmodulin is loosely bound to the
enzyme, and distinguishes the gastric mucosal en-
zyme from the Ca2q-dependent NO synthase present
w xin rabbit chondrocytes 17 .
w xThe instability of NO synthase 18 precluded the
incubation of the 10 000=g supernatants containing
the enzyme with agents likely to induce changes in
phosphorylation. However, the presence of ATP and
Mg2q during homogenisation caused a reduction in
enzyme activity. Substitution of ATP by GTP, or the
non-hydrolysable analogue of ATP adenylyl- b ,g-
.methylene -diphosphonate, did not reduce NO syn-
thase activity. These results strongly implicate phos-
phorylation by an ATP-dependent kinase as the cause
of the reduction of NO synthase activity. Indeed the
protein kinase C inhibitor, chelerythrine, partly pre-
vented the effect of ATP on NO synthase activity.
These data suggest that gastric mucosal NO synthase,
w xlike the brain enzyme 18 , can be inhibited by phos-
phorylation involving a form of protein kinase C.
Arginase was present in the gastric mucosa and in
isolated cells at an activity which was much higher
than that of NO synthase. However, arginase has a
w xhigh Km for arginine 19 and supply of substrate
could restrict arginase activity in intact tissue. The
distribution of arginase between cell fractions dif-
fered from that of NO synthase. For example, arginase
was lower, while NO synthase was higher, in the
high-density fraction than the unenriched fraction.
These results suggest that arginase is present in cells
which do not contain NO synthase.
The evidence that arginase was active in intact
isolated cells was that ornithine was formed from
w3 xH arginine, and that this conversion was reduced by
N G-hydroxy-L-arginine and L-ornithine. N G-hydroxy-
L-arginine, an intermediate of the NO synthase reac-
tion, is one of the most potent arginase inhibitors
known, with a K for competitive inhibition of liveri
w xarginase equal to 150 mM 15 . L-ornithine is also a
competitive inhibitor of arginase K for the liveri
. w xenzyme: 1 mM 19 , but does not inhibit NO syn-
w xthase 20 .
Citrulline formation could potentially have been
derived either from further metabolism of ornithine
by ornithine transcarbamoylase or by direct
metabolism of arginine by NO synthase. The pres-
ence of significant ornithine transcarbamoylase activ-
ity in isolated cells, and the inhibitory effect of the
arginase inhibitor L-ornithine on citrulline formation,
coupled with the lack of effect of N G-nitro-L-arginine,
suggests that the former pathway was predominant.
The concentration of N G-nitro-L-arginine used in
experiments with intact cells was 375 times the IC50
measured with the isolated enzyme so inhibition of
NO synthase in intact cells should have occurred. The
formation of citrulline from ornithine by gastric mu-
cosal cells resembles the situation in enterocytes
w x 2q9,21 , however in gastric cells NO synthase is Ca -
dependent while in intestinal cells it is Ca2q-indepen-
w xdent 9 .
In conclusion, gastric mucosal cells form citrulline
from exogenous arginine, but under the conditions
used in the present study, citrulline is formed pre-
dominantly by a pathway involving arginase rather
than NO synthase. Thus, if gut homogenates are used
to assay NO synthase by following formation of
radiolabelled citrulline from arginine, it is important
w xthat an arginase inhibitor is added 2 , and that only
product formation abolished by N G-monomethyl-L-
arginine or similar agents, which are not inhibitors of
w xarginase 22 , is taken as NO synthase. Arginase is
present in gastric mucosal cells, but its distribution
between cell-types is different from that of NO syn-
thase. Metabolism of arginine by cells in the gastric
glands might restrict the supply of arginine to NO
synthase in surface mucous cells, which could ex-
plain suggestions of an activation of gastric mucosal
NO synthase activity by arginine supplementation in
w xvivo 23,24 . Conversion of ornithine to citrulline
would enable resynthesis of arginine to occur in the
w xkidney 21 . The NO synthase present in isolated
gastric mucosal cells is of the nNOS group, which
extends the anatomical location of this isoform class
and warrants further molecular typing. A probable
function of the nNOS is to respond to increases in
intracellular Ca2q by producing NO, which is strongly
w ximplicated as an activator of mucin release 4,25 ,
w xand possibly an inhibitor of acid secretion 26 .
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